Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : BVX-0918C
Therapeutic Area : Oncology
Study Phase : Preclinical
Recipient : Biovaxys
Deal Size : Inapplicable
Deal Type : Inapplicable
International Patent Application Filed for Cervical Cancer Vaccine
Details : BioVaxys’s cancer vaccine BVX-0918C, created by extracting a patient’s own cancer cells, chemically treating them with a hapten, and re-injecting them into patient to induce an immune response to proteins which are otherwise not immunogenic.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
May 02, 2022
Lead Product(s) : BVX-0918C
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Recipient : Biovaxys
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
